| (210) | Number of the EPO application | 19386059 |
| (220) | Filing date of the EPO application | 2019.12.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 30/2022, 2022.07.27 |
| (110) | EPO patent number | 3845215 |
| (21) | Number of the application | e 2021 0943 |
| (71) | Name(s) of applicant(s), code of the country | LABOMED PHARMACEUTICAL COMPANY S.A., GR; |
| (72) | Name(s) of inventor(s), code of the country | LIOLIOS Georgios, GR;
PSARRAKIS Ioannis, GR; |
| (73) | Name(s) of owner(s), code of the country | LABOMED PHARMACEUTICAL COMPANY S.A., GR; |
| (54) | Title of the invention | ORAL SOLUTIONS COMPRISING LISDEXAMFETAMINE SALTS |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | A61K 9/00 (2006.01.01); A61K 9/08 (2006.01.01); A61K 31/4015 (2006.01.01); A61K 47/10 (2017.01.01); A61P 25/26 (2006.01.01) |
| (19) | Country | GR |
| (41) | Date of publication of the application | 2021.11.30 |